Impact BioMedical Inc.
IBO
$0.55
-$0.03-5.64%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 39.00K | 32.00K | 25.00K | 7.00K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 39.00K | 32.00K | 25.00K | 7.00K | -- |
| Cost of Revenue | 434.00K | 434.00K | 12.00K | 11.00K | -- |
| Gross Profit | -395.00K | -402.00K | 13.00K | -4.00K | -- |
| SG&A Expenses | 3.37M | 1.98M | 2.29M | 2.50M | 2.03M |
| Depreciation & Amortization | 1.15M | 1.15M | 1.14M | 1.13M | 1.12M |
| Other Operating Expenses | 358.00K | 406.00K | 447.00K | 383.00K | 285.00K |
| Total Operating Expenses | 5.59M | 4.30M | 4.01M | 4.17M | 3.64M |
| Operating Income | -5.55M | -4.27M | -3.99M | -4.17M | -3.64M |
| Income Before Tax | -15.46M | -14.45M | -44.21M | -38.49M | -25.02M |
| Income Tax Expenses | -2.58M | -2.58M | 33.00K | 33.00K | 33.00K |
| Earnings from Continuing Operations | -12.88 | -11.87 | -44.24 | -38.52 | -25.05 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 18.00K | 32.00K | 47.00K | 48.00K | 37.00K |
| Net Income | -12.86M | -11.84M | -44.19M | -38.47M | -25.02M |
| EBIT | -5.55M | -4.27M | -3.99M | -4.17M | -3.64M |
| EBITDA | -6.12M | -3.12M | -3.12M | -4.16M | -3.63M |
| EPS Basic | -1.26 | -1.34 | -3.76 | -3.27 | -2.18 |
| Normalized Basic EPS | -0.81 | -0.86 | -0.97 | -0.66 | 0.02 |
| EPS Diluted | -1.26 | -1.35 | -3.77 | -3.59 | -2.50 |
| Normalized Diluted EPS | -0.81 | -0.86 | -0.97 | -0.86 | -0.18 |
| Average Basic Shares Outstanding | 221.92M | 126.20M | 47.94M | 47.26M | 45.07M |
| Average Diluted Shares Outstanding | 221.92M | 126.20M | 47.94M | 107.76M | 105.57M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |